Literature DB >> 29938704

HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic.

George A Yendewa1,2, Eva Poveda3, Sahr A Yendewa4, Foday Sahr4,5, Miguel E Quiñones-Mateu1,6,7, Robert A Salata1,2.   

Abstract

Sierra Leone is a low-income West African country that has dealt with waves of economic, political, and public health challenges in its recent past, including a decade-long brutal civil war and the Ebola epidemic of 2014-2016. The HIV/AIDS epidemic, which has raged on in the country since 1987, has long been characterized as stable. The latest UNAIDS report estimates a countrywide HIV prevalence rate of 1.7% in 2016 among adults aged 15-49 years. However, there are indications that the epidemic may be in fact escalating and unless arrested urgently, has the potential to deteriorate into a major public health emergency. Although there are high levels of HIV awareness among adults (over 94%), uptake in voluntary HIV testing has remained low (<30%), and under one-third (29%) of the country's 60,000 people living with HIV/AIDS were on antiretroviral therapy in 2015. This review attempts to address the paucity of scientific information on the subject by presenting the historical and epidemiological background to the HIV/AIDS epidemic in Sierra Leone. Other aspects of the HIV/AIDS epidemic in Sierra Leone are examined, including routine HIV screening and diagnosis, linkage to and retention in HIV care, clinical characteristics and molecular epidemiology, treatment coverage, and prevention strategies. Finally, we identify four key areas of challenge that are hampering current efforts attempting to bring the epidemic under control, and perspective is offered on the way forward.

Entities:  

Keywords:  HIV; Sierra Leone; Antiretroviral therapy; Diagnostics; Resource-limited settings

Mesh:

Substances:

Year:  2018        PMID: 29938704     DOI: 10.24875/AIDSRev.M18000022

Source DB:  PubMed          Journal:  AIDS Rev        ISSN: 1139-6121            Impact factor:   2.500


  12 in total

1.  Seroprevalence of Hepatitis B, Hepatitis C, and Human T-Cell Lymphotropic Virus Infections in HIV-Infected Patients in Sierra Leone.

Authors:  George A Yendewa; Foday Sahr; Antonio Aguilera; Sulaiman Lakoh; Momodu Sesay; Gibrilla F Deen; Lucia Patiño; Eva Poveda; Robert A Salata
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

2.  COVID-19 Vaccine Hesitancy among Healthcare Workers and Trainees in Freetown, Sierra Leone: A Cross-Sectional Study.

Authors:  Sahr A Yendewa; Manal Ghazzawi; Peter B James; Mohamed Smith; Samuel P Massaquoi; Lawrence S Babawo; Gibrilla F Deen; James B W Russell; Mohamed Samai; Foday Sahr; Sulaiman Lakoh; Robert A Salata; George A Yendewa
Journal:  Vaccines (Basel)       Date:  2022-05-11

3.  High Prevalence of Late-Stage Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Sierra Leone.

Authors:  George A Yendewa; Eva Poveda; Sulaiman Lakoh; Sahr A Yendewa; Darlinda F Jiba; Angel Salgado-Barreira; Foday Sahr; Robert A Salata
Journal:  Open Forum Infect Dis       Date:  2018-08-23       Impact factor: 3.835

4.  Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone.

Authors:  George A Yendewa; Foday Sahr; Sulaiman Lakoh; Marta Ruiz; Lucia Patiño; Andrés Tabernilla; Gibrilla F Deen; Momodu Sesay; Robert A Salata; Eva Poveda
Journal:  J Antimicrob Chemother       Date:  2019-07-01       Impact factor: 5.790

5.  Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study.

Authors:  Sulaiman Lakoh; Darlinda F Jiba; Joseph E Kanu; Eva Poveda; Angel Salgado-Barreira; Foday Sahr; Momodu Sesay; Gibrilla F Deen; Tom Sesay; Wadzani Gashau; Robert A Salata; George A Yendewa
Journal:  BMC Public Health       Date:  2019-10-21       Impact factor: 3.295

6.  Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study.

Authors: 
Journal:  Lancet HIV       Date:  2021-06       Impact factor: 16.070

7.  Prevalence of risk factors for human immunodeficiency virus among women of reproductive age in Sierra Leone: a 2019 nationwide survey.

Authors:  Joseph Kawuki; Kassim Kamara; Quraish Sserwanja
Journal:  BMC Infect Dis       Date:  2022-01-17       Impact factor: 3.090

8.  Multidrug-resistant tuberculosis in Sierra Leone.

Authors:  Sulaiman Lakoh; George A Yendewa
Journal:  Lancet Glob Health       Date:  2022-04       Impact factor: 38.927

9.  A Prospective Study of Etiological Agents Among Febrile Patients in Sierra Leone.

Authors:  Han Wang; Jing Zhao; Na Xie; Wanxue Wang; Ruping Qi; Xiaogang Hao; Yan Liu; Stephen Sevalie; Guotao Niu; Yangli Zhang; Ge Wu; Xiaona Lv; Yuhao Chen; Yanfei Ye; Sheng Bi; Moses Moseray; Saidu Cellessy; Ksaidu Kalon; Dawud Ibrahim Baika; Qun Luo
Journal:  Infect Dis Ther       Date:  2021-06-26

10.  Characterizing HIV-1 Genetic Subtypes and Drug Resistance Mutations among Children, Adolescents and Pregnant Women in Sierra Leone.

Authors:  George A Yendewa; Sulaiman Lakoh; Sahr A Yendewa; Khadijah Bangura; Andrés Tabernilla; Lucia Patiño; Darlinda F Jiba; Alren O Vandy; Samuel P Massaquoi; Nuno S Osório; Gibrilla F Deen; Foday Sahr; Robert A Salata; Eva Poveda
Journal:  Genes (Basel)       Date:  2021-08-26       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.